{"output": [["Celgene Corp", "COMP", "Acquire", "Impact Biomedicines", "COMP"], ["Impact Biomedicines", "COMP", "Produce", "fedratinib", "PRODUCT"], ["fedratinib", "PRODUCT", "Relate_To", "myelofibrosis", "CONCEPT"], ["Celgene Corp", "COMP", "Operate_In", "bio-technology sector", "SECTOR"], ["Celgene Corp", "COMP", "Pay", "$1.1B", "FIN_INSTRUMENT"], ["Celgene Corp", "COMP", "Pay", "additional $1.4B", "FIN_INSTRUMENT"], ["Celgene Corp", "COMP", "Pay", "maximum of $4.5B", "FIN_INSTRUMENT"], ["Impact Biomedicines", "COMP", "Located_In", "San Diego", "GPE"]], "published": "2018-01-08T05:27:00.000+02:00"}